Statistics for Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Total visits
| views | |
|---|---|
| Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma | 252 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
Top country views
| views | |
|---|---|
| United States | 193 |
| Germany | 24 |
| Ukraine | 5 |
| Russia | 4 |
| Canada | 2 |
| United Kingdom | 2 |
| Switzerland | 1 |
| China | 1 |
| France | 1 |
| Japan | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 55 |
| Fairfield | 34 |
| Kiez | 20 |
| Houston | 15 |
| Cambridge | 14 |
| Ann Arbor | 12 |
| Jacksonville | 7 |
| Kiev | 5 |
| Gunzenhausen | 4 |
| Saint Petersburg | 3 |
| Washington | 3 |
| Baltimore | 2 |
| Brooklyn | 2 |
| Kansas City | 2 |
| Lake Mary | 2 |
| Toronto | 2 |
| Abingdon | 1 |
| Avon | 1 |
| Cointrin | 1 |
| Norwalk | 1 |
| Philadelphia | 1 |
| Roubaix | 1 |
| Ryazan | 1 |
| San Francisco | 1 |
| Seremban | 1 |